|4Nov 24, 4:52 PM ET

AUXILIUM PHARMACEUTICALS INC 4

4 · AUXILIUM PHARMACEUTICALS INC · Filed Nov 24, 2014

Insider Transaction Report

Form 4
Period: 2014-11-21
Armstrong Jennifer Lou
Senior Vice President, HR
Transactions
  • Exercise/Conversion

    Common Stock

    2014-11-21$15.12/sh+11,250$170,10072,927 total
  • Exercise/Conversion

    Common Stock

    2014-11-21$19.51/sh+14,000$273,14086,927 total
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-2122,0000 total
    Exercise: $31.85From: 2010-07-27Exp: 2019-07-27Common Stock (22,000 underlying)
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-2111,2503,750 total
    Exercise: $15.12From: 2012-11-01Exp: 2021-11-01Common Stock (11,250 underlying)
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-213,75011,250 total
    Exercise: $18.30From: 2014-02-07Exp: 2023-02-07Common Stock (3,750 underlying)
  • Exercise/Conversion

    Common Stock

    2014-11-21$31.85/sh+22,000$700,70043,265 total
  • Exercise/Conversion

    Common Stock

    2014-11-21$30.20/sh+11,100$335,22054,365 total
  • Exercise/Conversion

    Common Stock

    2014-11-21$22.04/sh+7,312$161,15661,677 total
  • Exercise/Conversion

    Common Stock

    2014-11-21$18.30/sh+3,750$68,62590,677 total
  • Sale

    Common Stock

    2014-11-21$33.50/sh69,412$2,325,03114,874 total
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-2114,00014,000 total
    Exercise: $19.51From: 2013-02-14Exp: 2022-02-13Common Stock (14,000 underlying)
  • Sale

    Common Stock

    2014-11-21$33.50/sh6,391$214,07584,286 total
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-2111,1000 total
    Exercise: $30.20From: 2011-02-28Exp: 2020-02-29Common Stock (11,100 underlying)
  • Exercise/Conversion

    Nonqualified Stock Option (Right to Buy)

    2014-11-217,3122,438 total
    Exercise: $22.04From: 2012-02-17Exp: 2021-02-17Common Stock (7,312 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $33.38 to $33.55, inclusive.
  • [F2]The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $33.38 to $33.58, inclusive.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION